Cereset®, the acoustic neuromodulation wellness company backed by 15 years of peer-reviewed research with Wake Forest School of Medicine, launched BrainEcho® NetworkFlow™ – the most significant ...
NeuWire Medical, a medical device company advancing the development of a targeted plasticity therapy platform for individuals living with chronic ischemic stroke, today announced the appointment of ...
NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic ...
The increasing prevalence of chronic disorders, shift towards non-opioid-based treatment, technological advancement in device ...
A novel, noninvasive brain stimulation approach—known as transcranial temporal interference stimulation (TIs)—may offer a new ...
MINNEAPOLIS, May 11, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative ...
Boston Scientific's Neuromodulation unit posts 15% organic sales growth in Q1, fueled by pain management gains, the ...
The treatment consists of a Bluetooth headset that patients can connect to an app on their smartphones. It could mark a ...
Experts are already treating addicted people with at-home neuromodulation devices to control cravings, and the future is ...
Hinge Health boosted its full-year revenue outlook by $64 million as the company reported a stronger-than-expected first ...
Resmed Corp. has agreed to acquire Noctrix Health Inc. for $340 million, boosting its sleep health portfolio. Noctrix has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results